Our Programmes

Browse our EQA programmes available list below. Here you’ll find programmes relating to autoimmunity, allergy & immunodeficiency, and immunochemistry. Download information easily from our links below.

 

AUTOIMMUNITY PROGRAMMES

General Autoimmune Serology

    • This scheme has been reconfigured into 4 new programmes:
      • Rheumatoid Antibodies
      • Thyroid Antibodies
      • Anaemia Related Antibodies
      • Liver Disease Antibodies

Rheumatoid Antibodies

  • Rheumatoid Factor (SER/001)
  • Citrullinated Proteins (SER/036)

Thyroid Antibodies

  • Thyroid Microsome Antibody/TPO (SER/002)
  • Thyroid Stimulating Hormone Receptor Antibody/TRAb (SER/048)

Anaemia Related Antibodies

  • Gastric Parietal Cell Antibodies (SER/034)

Liver Disease Antibodies

  • Identification of antibodies associated with autoimmune liver disease (SER/004)
    • To include Mitochondrial antibodies, Liver Kidney Microsomal (LKM) antibodies, Smooth Muscle Antibodies (SMA) and other liver antibodies (PML, Ro-52)

Nuclear & Related Antibodies

  • Nuclear Antibodies (ANA/DNA/ENA) (SER/005)
  • Nuclear Antibodies (ANA/DNA) (SER/003)

Anti Phospholipid Antibodies (SER/006)

Autoimmune Serology ANCA and GBM (SER/007)

Acetylcholine Receptor Antibodies (ACR) Antibody (SER/008)

Bullous Dermatosis Antibodies (SER/009)

Coeliac Disease Antibodies (SER/010)

Interferon Gamma Release Assays (SER/039)

Paraneoplastic Antibodies (SER/038)

Diabetic Markers (SER/047)

Ganglioside Antibody (SER/050)

Myositis Associated Antibodies (SER/054)

Phospholipase Receptor 2 Antibodies (SER/055)

Myelin Associated Glycoprotein IgM Antibodies (SER/057)

COVID-19/SARS CoV-2 Antibodies (SER/059)

Pilot - N-Methyl-D-Aspartate Receptor Antibodies (NMDAR) SER/062

 

ALLERGY & IMMUNODEFICIENCY PROGRAMMES

Fungal & Related Antigens

  • Fungal Antibodies (SER/016)
  • Avian Antibodies (SER/017)

IgG Subclasses (SER/018)

Specific Microbial Antibodies

  • Tetanus Antibodies (SER/043)
  • H.Influenzae Antibodies (SER/044)
  • Pneumococcal Antibodies (SER/045)

Total Serum IgE (SER/031)

Allergen Specific IgE (SER/032)

Allergen Component Testing (SER/051)

Tryptase (SER/040)

 

IMMUNOCHEMISTRY PROGRAMMES

Alkaline Phosphatase Isoenzymes (SER/056)

Beta 2 Microglobulin (SER/013)

C1 Inhibitor and Functional Complement (SER/033)

C-Reactive Protein and Procalcitonin

  • CRP (SER/014)
  • Procalcitonin (SER/061)

Pilot - Point of Care C-Reactive Protein Testing (POC/555)

CRP Ultrasensitive Assays (SER/028)

CSF Oligoclonal Bands (SER/015)

CSF Haem Pigments (SER/042)

CSF Proteins & Biochemistry (SER/041)

Alpha 1 Antitrypsin Phenotype Identification (SER/037)

CSF Beta 2 Transferrin / Beta Trace Protein (SER/046)

Interleukin-6 (SER/060)

 

ONCOLOGY PROGRAMMES

Monoclonal Proteins (SER/019)

Total PSA (SER/020) & Free PSA (SER/030)

Tumour Markers

  • Ovarian Markers (CA125) (SER/021)
  • Gut Markers (CA199) (SER/022)
  • Breast Markers (CA153) (SER/023)
  • Lung Markers (NSE) (SER/024)
  • Chromogranin A (SER/049)

Ultrasensitive PSA (SER/058)

 

DIGITAL PROGRAMMES

Digital ANA (image based) (DA/601)

Pilot Cryoprotein (image based) (SER/052)

 

NEW PILOT PROGRAMMES

Immunoglobulin D (IgD) SER/063

Scleroderma (SCL) SER/064

Anti-TNF Drugs and Antibodies (TNFA (SER/065) / TNFI (SER/066))

 

Download our EQA Programmes and Register Today

Don’t hesitate to contact us for further information, and register here today. Alongside our EQA Programmes, you can also download educational resources from our Digital Academy, including webinars, commentaries, videos and more.

 

FAQs

What is an EQA programme?

An EQA programme is a quality assurance scheme designed to assess the performance of laboratories or testing facilities by comparing their results with those of other participating laboratories using the same methods or standards.

What are the benefits of participating in EQA programmes?

Participating in EQA programmes offers several benefits, including benchmarking performance against peers, identifying areas for improvement, enhancing confidence in test results, meeting regulatory requirements, demonstrating competence to clients or stakeholders, and fostering continuous professional development.